HOMOLOGY MEDICINES INC (FIXX) Stock Earnings & Estimates
NASDAQ:FIXX - US4380831077 - Common Stock
0.9347 USD
+0.01 (+0.77%)
0.892 USD
-0.04 (-4.57%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 33.97M 1,158.15% | 3.21M -90.55% | 1.156M -63.99% | -100.00% | 2.04M | 2.04M | 2.04M | 2.04M | 350.88M 17,100.00% | 460.53M 31.25% | |
| EBITDA YoY % growth | -87.6M 28.37% | -131.99M -50.67% | -91.524M 30.66% | -147.457M -61.11% | -169.4M -14.88% | 32.538M 119.21% | 163.51M 402.52% | N/A | N/A | N/A | |
| EBIT YoY % growth | -95.95M 26.34% | -133.28M -38.91% | -92.102M 30.90% | -27.302M 70.36% | -41.31M -51.31% | -38.25M 7.41% | -35.19M 8.00% | -32.64M 7.25% | 70.89M 317.19% | 164.22M 131.65% | |
| Operating Margin | -282.46% | -4,152.02% | -7,967.30% | N/A | -2,025.00% | -1,875.00% | -1,725.00% | -1,600.00% | 20.20% | 35.66% | |
| EPS YoY % growth | -1.69 39.64% | -1.90 -12.43% | -1.96 -3.16% | -0.70 64.09% | -0.72 -1.59% | -1.31 -83.55% | -0.98 25.13% | -0.32 67.30% | 0.32 198.41% | 1.23 288.71% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 53.08% | -0.17 71.57% | -0.15 73.16% | -0.14 49.00% |
| Revenue Q2Q % growth | -100.00% | -100.00% | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.051M 63.46% | -6.556M 78.73% | -5.634M 76.87% | -5.062M 46.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.28 53.33% | -0.31 | 0.03 | 8.50% |
| Q3 2023 Q2Q % growth | -0.57 3.39% | -0.43 | -0.14 | -33.05% |
| Q2 2023 Q2Q % growth | -0.61 -19.61% | -0.48 | -0.13 | -25.90% |
| Q1 2023 Q2Q % growth | -0.50 -150.00% | -0.54 | 0.04 | 7.51% |
| Q4 2022 Q2Q % growth | -0.60 -1.69% | -0.51 | -0.09 | -16.77% |
| Q3 2022 Q2Q % growth | -0.59 -9.26% | -0.48 | -0.11 | -22.42% |
| Q2 2022 Q2Q % growth | -0.51 5.56% | -0.57 | 0.06 | 9.97% |
| Q1 2022 Q2Q % growth | -0.20 -900.00% | -0.36 | 0.16 | 43.98% |
| Q4 2021 Q2Q % growth | -0.59 4.84% | -0.60 | 0.01 | 2.33% |
| Q3 2021 Q2Q % growth | -0.54 12.90% | -0.61 | 0.07 | 11.72% |
| Q2 2021 Q2Q % growth | -0.54 30.77% | -0.60 | 0.06 | 10.57% |
| Q1 2021 Q2Q % growth | -0.02 97.44% | -0.68 | 0.66 | 97.07% |
| Q4 2020 Q2Q % growth | -0.62 -12.73% | -0.69 | 0.07 | 10.02% |
| Q3 2020 Q2Q % growth | -0.62 7.46% | -0.82 | 0.20 | 24.42% |
| Q2 2020 Q2Q % growth | -0.78 -27.87% | -0.78 | 0.00 | -0.33% |
| Q1 2020 Q2Q % growth | -0.78 -21.88% | -0.69 | -0.09 | -12.29% |
| Q4 2019 Q2Q % growth | -0.55 | -0.70 | 0.15 | 21.04% |
| Q3 2019 Q2Q % growth | -0.67 | -0.61 | -0.06 | -9.72% |
| Q2 2019 Q2Q % growth | -0.61 | -0.56 | -0.05 | -9.18% |
| Q1 2019 Q2Q % growth | -0.64 | -0.54 | -0.10 | -18.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | 510K | -510K | -100.00% |
| Q2 2023 Q2Q % growth | 350K -56.25% | 858.157K | -508.157K | -59.21% |
| Q1 2023 Q2Q % growth | 800K | 1.035M | -235K | -22.71% |
| Q4 2022 Q2Q % growth | 800K | 847.008K | -47.008K | -5.55% |
| Q3 2022 Q2Q % growth | 800K -52.38% | 877.608K | -77.608K | -8.84% |
| Q2 2022 Q2Q % growth | 800K -63.47% | 1.021M | -221K | -21.65% |
| Q1 2022 Q2Q % growth | 800K -97.27% | 21.106M | -20.306M | -96.21% |
| Q4 2021 Q2Q % growth | 800K -18.37% | 756.728K | 43.272K | 5.72% |
| Q3 2021 Q2Q % growth | 1.68M 194.74% | 701.25K | 978.75K | 139.57% |
| Q2 2021 Q2Q % growth | 2.19M 284.21% | 438.294K | 1.752M | 399.66% |
| Q1 2021 Q2Q % growth | 29.31M 4,867.80% | 527.595K | 28.782M | 5,455.40% |
| Q4 2020 Q2Q % growth | 980K 75.00% | 1.148M | -168K | -14.63% |
| Q3 2020 Q2Q % growth | 570K 29.55% | 491.64K | 78.36K | 15.94% |
| Q2 2020 Q2Q % growth | 570K 46.15% | 525.637K | 44.363K | 8.44% |
| Q1 2020 Q2Q % growth | 590K 118.52% | 581.4K | 8.6K | 1.48% |
| Q4 2019 Q2Q % growth | 560K | 1.246M | -686K | -55.06% |
| Q3 2019 Q2Q % growth | 440K | 467.497K | -27.497K | -5.88% |
| Q2 2019 Q2Q % growth | 390K | 816K | -426K | -52.21% |
| Q1 2019 Q2Q % growth | 270K | 994.5K | -724.5K | -72.85% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |